-
BFH772 (VEGFR2 inhibitor) Protocol Guide
2026-08-12
BFH772 is a selective VEGFR2 inhibitor for research workflows that require targeted modulation of VEGFR2-associated angiogenic signaling, including endothelial and tumor angiogenesis models. It is best suited to assays using validated organic-solvent stocks and should not be selected for water-based formulations, broad-spectrum kinase screening, or studies requiring a defined in vivo dose regimen without additional optimization.
-
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-11
The 2025 reference study identifies naturally occurring angiotensin peptides as sequence-dependent enhancers of SARS-CoV-2 spike binding to AXL, with Angiotensin IV also affecting ACE2 and NRP1. Its antibody-based binding experiments support a mechanistic link between renin–angiotensin peptide processing and viral receptor engagement, while leaving cellular infection and in vivo relevance to future validation.
-
Lisinopril Dihydrate: ACE Inhibitor Workflows
2026-08-11
Build reproducible ACE-inhibition assays and cardiorenal disease models with a water-compatible, nanomolar lisinopril dihydrate workflow. The guide connects biochemical target engagement to hypertension, heart failure, myocardial infarction, and diabetic nephropathy readouts while addressing selectivity and handling risks.
-
(+)-Bicuculline: Protocol and QC Guide
2026-08-10
This guide explains how to use (+)-Bicuculline as a GABAA receptor antagonist in synaptic transmission, neuronal signaling, and related assay workflows, with emphasis on solubility, storage, controls, and interpretation. It is a research reagent only and should not be used for diagnostic, therapeutic, or clinical applications.
-
Angiotensin Peptides and SARS-CoV-2 Receptor Binding
2026-08-09
Oliveira et al. show that endogenous angiotensin peptides can enhance SARS-CoV-2 spike-protein binding to AXL and, for angiotensin IV, to ACE2 and NRP1. The study identifies peptide length and tyrosine modification as important determinants, creating a mechanistic bridge between renin–angiotensin system biology and viral receptor engagement.
-
EZ Cap™ EGFP mRNA (5-moUTP): Assay Guide
2026-08-08
Learn how EZ Cap™ EGFP mRNA (5-moUTP), SKU R1016, can help separate transfection performance from cell-health effects in viability, proliferation, and cytotoxicity workflows. This scenario-driven guide covers assay design, handling, interpretation, vendor selection, and the limits of translating reporter results to in vivo delivery studies.
-
Paroxetine Mesylate: Neuro-Oncology & Cardiac Translation
2026-08-07
Paroxetine Mesylate is more than a Selective serotonin reuptake inhibitor: its SERT activity, CYP2D6 inhibition, kinase interactions, and relevance to colorectal cancer and epilepsy-associated cardiac biomarkers create a practical framework for translational research.
-
ECL Western Blotting Substrate: Technical Protocol and QC Gu
2026-08-07
ECL Western Blotting Substrate (SKU K2187) provides a sensitive, nonradioactive solution for detecting horseradish peroxidase (HRP) in Western blot assays. It is optimal for chemiluminescent protein detection in molecular biology, cancer biology, and signal transduction pathway workflows, but is not suitable for fluorescent or radioisotopic methods.
-
Angiotensin III: Mechanisms, Strategy, and Translational Fro
2026-08-06
This thought-leadership article explores Angiotensin III (human, mouse) as more than a classical RAAS component—detailing its mechanistic nuances, experimental leverage, and emerging significance in both cardiovascular and viral pathogenesis research. Integrating the latest mechanistic findings and strategic protocols, the article empowers translational researchers to harness Angiotensin III’s specificity and solubility for cutting-edge applications, while critically assessing cross-domain implications and future directions.
-
METTL16-SENP3-LTF Axis Drives Ferroptosis Resistance in HCC
2026-08-06
Wang et al. (2024) uncover a METTL16-SENP3-LTF signaling axis that confers resistance to ferroptosis and enhances tumorigenesis in hepatocellular carcinoma. Their mechanistic insights reveal new opportunities for targeting iron metabolism and cell death pathways in HCC therapy.
-
Microglial Nr4a1 and Neuronal C3 in TMJ-Induced Hippocampal
2026-08-05
This study uncovers how TMJ inflammation drives depression-like behaviors in mice through microglial Nr4a1 deficiency and neuronal C3–mediated synaptic pruning in the hippocampus. The findings highlight novel mechanistic targets for addressing neuropsychiatric complications of orofacial inflammation.
-
Angiotensin 1/2 (2-7): Bridging Cardiovascular and Viral Res
2026-08-05
Explore the dual mechanistic roles and translational strategies for leveraging the Angiotensin 1/2 (2-7) peptide in both blood pressure regulation and viral pathogenesis research. This thought-leadership article draws on new molecular insights, experimental protocols, and strategic guidance that elevate the conversation beyond standard peptide studies, anchoring APExBIO’s offering at the forefront of next-generation discovery.
-
Small-Molecule Disruption of uPAR-uPA Inhibits Breast Cancer
2026-08-04
This study presents the synthesis and validation of a small-molecule inhibitor targeting the uPAR–uPA protein–protein interaction, a key driver of breast cancer metastasis. The compound demonstrated sub-micromolar affinity, robust inhibition of tumor invasion in vitro, and reduced lung metastasis in vivo, providing a promising scaffold for future therapeutic development.
-
Naked Mole-Rat cGAS Enhances DNA Repair and Delays Aging
2026-08-04
This study reveals that naked mole-rats possess a unique form of the DNA sensor cGAS, which, through four specific amino acid changes, enhances homologous recombination repair and attenuates aging. The findings provide mechanistic insight into longevity and genome stability, with implications for research on protein homeostasis and DNA repair modulation.
-
Honokiol as a Precision NF-κB Pathway Inhibitor in Cancer Re
2026-08-03
Honokiol stands out as an advanced tool for dissecting NF-κB-driven inflammation and tumor biology, offering high purity and robust solubility for in vitro workflows. This guide translates cutting-edge reference insights into actionable protocols, troubleshooting, and comparative analysis for cell-based assays.